Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial

Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression

(2016) C. K. Loo et al.   ACTA PSYCHIATRICA SCANDINAVICA

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

(2016) Panos Zanos et al.   NATURE

Comments on Cooper et al.’s review on strategies to mitigate dissociative and psychotomimetic effects from ketamine when used as a fast-acting antidepressant

(2016) Paul Glue et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis

(2015) Ying Xu et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Intranasal Drug Delivery in Neuropsychiatry: Focus on Intranasal Ketamine for Refractory Depression

(2015) Chittaranjan Andrade   JOURNAL OF CLINICAL PSYCHIATRY

Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study

(2015) Y.-D. Hu et al.   PSYCHOLOGICAL MEDICINE

A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder

(2014) Kyle A.B. Lapidus et al.   BIOLOGICAL PSYCHIATRY

Do the dissociative side effects of ketamine mediate its antidepressant effects?

(2014) David A. Luckenbaugh et al.   JOURNAL OF AFFECTIVE DISORDERS

A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes

(2014) A. McGirr et al.   PSYCHOLOGICAL MEDICINE

Pilot dose–response trial of i.v. ketamine in treatment-resistant depression

(2014) Rosalyn Lai et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial

(2013) James W. Murrough et al.   AMERICAN JOURNAL OF PSYCHIATRY

Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression

(2013) Paulo R. Shiroma et al.   JOURNAL OF AFFECTIVE DISORDERS

Repeated S-ketamine Infusions in Therapy Resistant Depression: A Case Series

(2013) Felix Segmiller et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Serial infusions of low-dose ketamine for major depression

(2013) Keith G Rasmussen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial

(2012) Carlos A. Zarate et al.   BIOLOGICAL PSYCHIATRY

Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression

(2012) James W. Murrough et al.   BIOLOGICAL PSYCHIATRY

Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research

(2012) Adam J. Guastella et al.   PSYCHONEUROENDOCRINOLOGY

Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review

(2012) Per Gisle Djupesland   Drug Delivery and Translational Research

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

The Bladder Pain/Interstitial Cystitis Symptom Score: Development, Validation, and Identification of a Cut Score

(2011) Louise Humphrey et al.   EUROPEAN UROLOGY

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

(2010) Nancy Diazgranados et al.   ARCHIVES OF GENERAL PSYCHIATRY

Rapid development of tolerance to sub-anaesthetic dose of ketamine: an oculomotor study in macaque monkeys

(2010) Pierre Pouget et al.   PSYCHOPHARMACOLOGY

Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression

(2009) Marije aan het Rot et al.   BIOLOGICAL PSYCHIATRY